Latest Orna Therapeutics News & Updates

See the latest news and media coverage for Orna Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Orna Therapeutics

Developer of engineered circular RNA therapeutics

ornatx.com
Headquarters
Watertown, United States
Founded year
2019
Company type
Private company
Number of employees
150–200

Last updated

Latest news about Orna Therapeutics

Company announcements

  • Orna Therapeutics

    Lilly agrees to acquire Orna Therapeutics

    The deal, worth up to $2.4 billion, advances Orna's in vivo CAR-T therapies for autoimmune diseases using circular RNA.

  • Orna Therapeutics

    Orna Therapeutics shares new data at ASH 2025

    They presented posters and oral sessions on oRNA® technology for in vivo pan-CAR therapies targeting multiple myeloma and autoimmune diseases.

  • Orna Therapeutics

    Orna Therapeutics presents preclinical data on in vivo CAR programs

    Data supports anti-CD19 ORN-252 for autoimmune diseases and anti-BCMA for oncology, shown at ASH 2025. Plans CTA submission by end 2025.

  • Orna Therapeutics

    Orna Therapeutics announces presentations at ASH 2025

    Presentations highlight in vivo CAR programs for autoimmune diseases and anti-BCMA platform, including NHP study data and CTA submission plans.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Orna Therapeutics

Track Orna Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.